Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Thyroid and reproductive hormones, BMI, and excess hair are linked in Iraqi women with PCOS.

Intralesional steroids can help regrow hair in some alopecia areata patients but have side effects.

Including ineffective or unsafe doses in reviews can lead to misleading conclusions about alopecia areata treatments.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

Androgenetic alopecia is linked to higher cardiovascular and metabolic risks, possibly due to irisin resistance.

AQB reduces harmful skin changes in systemic sclerosis.

Oral Janus kinase inhibitors are effective for treating alopecia areata in adults.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Oral isotretinoína effectively stabilizes frontal fibrosing alopecia.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

Ipilimumab can cause various adverse events in elderly patients, especially affecting the gastrointestinal and endocrine systems.

PRX01, PRX44, and PRX73 are essential for root hair growth in Arabidopsis thaliana.

Giardiasis in dogs poses a public health risk, requiring better diagnosis, treatment, and sanitation.

Steroid 5α-reductase evolved from protists and diversified in eukaryotes, with specific roles in mammals and plants.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

Researchers identified a new hair loss pattern called "sisaipho type," where hair is lost across the scalp except around the edges.

Five new mutations in the androgen receptor gene were found, helping to understand androgen insensitivity syndrome better.

Baricitinib is effective and safe for treating severe alopecia areata for up to 5 years.

Using 5α-reductase inhibitors for hair loss can cause lasting sexual, physical, mental, and vascular health issues in men, even after stopping the medication.

Men using 5-alpha reductase inhibitors for prostate issues may have a slightly higher risk of blood clots.

The HtrA1L364P mutation causes brain dysfunction and blood vessel damage.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

5α-Reductase inhibitors can negatively affect male sexual function and, in some cases, significantly reduce sperm count, but these effects may be reversible.